Addex Therapeutics Ltd (ADXN)
10.70
+0.95
(+9.74%)
USD |
NASDAQ |
Nov 01, 16:00
10.77
+0.07
(+0.65%)
After-Hours: 20:00
Addex Therapeutics Price to Book Value: 0.8125 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 0.8125 |
| October 31, 2024 | 0.7404 |
| October 30, 2024 | 0.814 |
| October 29, 2024 | 0.7905 |
| October 28, 2024 | 0.8361 |
| October 25, 2024 | 0.8361 |
| October 24, 2024 | 0.8778 |
| October 23, 2024 | 0.8247 |
| October 22, 2024 | 0.8102 |
| October 21, 2024 | 0.7821 |
| October 18, 2024 | 0.7928 |
| October 17, 2024 | 0.8049 |
| October 16, 2024 | 0.8011 |
| October 15, 2024 | 0.7935 |
| October 14, 2024 | 0.7973 |
| October 11, 2024 | 0.7791 |
| October 10, 2024 | 0.7852 |
| October 09, 2024 | 0.7776 |
| October 08, 2024 | 0.7852 |
| October 07, 2024 | 0.7089 |
| October 04, 2024 | 0.7168 |
| October 03, 2024 | 0.7138 |
| October 02, 2024 | 0.7047 |
| October 01, 2024 | 0.7009 |
| September 30, 2024 | 0.7419 |
| Date | Value |
|---|---|
| September 27, 2024 | 0.6872 |
| September 26, 2024 | 0.7313 |
| September 25, 2024 | 0.7556 |
| September 24, 2024 | 0.7753 |
| September 23, 2024 | 0.8049 |
| September 20, 2024 | 0.7472 |
| September 19, 2024 | 0.7343 |
| September 18, 2024 | 0.7282 |
| September 17, 2024 | 0.7692 |
| September 16, 2024 | 0.767 |
| September 13, 2024 | 0.732 |
| September 12, 2024 | 0.7753 |
| September 11, 2024 | 0.7821 |
| September 10, 2024 | 0.8005 |
| September 09, 2024 | 0.8338 |
| September 06, 2024 | 0.849 |
| September 05, 2024 | 0.8588 |
| September 04, 2024 | 0.8125 |
| September 03, 2024 | 0.8717 |
| August 30, 2024 | 0.8247 |
| August 29, 2024 | 0.7768 |
| August 28, 2024 | 0.8057 |
| August 27, 2024 | 0.8793 |
| August 26, 2024 | 0.5817 |
| August 23, 2024 | 0.5809 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4725
Minimum
Jun 28 2022
10.18
Maximum
Jan 29 2024
2.401
Average
2.146
Median
Price to Book Value Benchmarks
| AC Immune SA | 2.162 |
| CRISPR Therapeutics AG | 2.182 |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | 1.174 |
| MoonLake Immunotherapeutics | 5.648 |
Price to Book Value Related Metrics
| PS Ratio | 10.19 |
| Price | 10.70 |
| Earnings Yield | -15.35% |
| Market Cap | 11.44M |